- Report
- January 2026
- 187 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- July 2026
- 120 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- May 2026
- 230 Pages
Global
From €4225EUR$4,650USD£3,631GBP
- Report
- June 2026
- 593 Pages
Global
From €4084EUR$4,495USD£3,510GBP
- Report
- April 2026
- 135 Pages
Global
From €2725EUR$2,999USD£2,342GBP
€3634EUR$3,999USD£3,123GBP
- Report
- September 2026
- 195 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 183 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- April 2026
- 430 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- September 2026
- 274 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 372 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 376 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- June 2026
- 200 Pages
Middle East
From €2717EUR$2,990USD£2,335GBP
- Report
- November 2022
- 295 Pages
Global
From €4498EUR$4,950USD£3,866GBP
- Report
- May 2026
- 17 Pages
Global
From €453EUR$499USD£390GBP
- Report
- August 2025
- 200 Pages
United States
From €2263EUR$2,490USD£1,945GBP
- Report
- March 2025
- 120 Pages
Global
From €4452EUR$4,900USD£3,827GBP
- Report
- January 2024
- 92 Pages
Europe
From €2680EUR$2,950USD£2,304GBP

The Cancer Profiling market within the Diagnostics industry is focused on the development of tests that can detect the presence of cancer in a patient. These tests are used to identify the type of cancer, its stage, and the best treatment options. Cancer profiling tests are used to detect genetic mutations, which can help doctors determine the best course of treatment for a patient. These tests are also used to monitor the progress of a patient's cancer treatment.
The Cancer Profiling market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Roche. Show Less Read more